G Merli

Summary

Affiliation: Thomas Jefferson University
Country: USA

Publications

  1. ncbi request reprint The new oral anticoagulants: a challenge for hospital formularies
    Geno J Merli
    Thomas Jefferson University Hospitals, Philadelphia, PA
    Hosp Pract (1995) 40:126-8. 2012
  2. doi request reprint Real-world practices to prevent venous thromboembolism with pharmacological prophylaxis in US orthopedic surgery patients: an analysis of an integrated healthcare database
    G J Merli
    Jefferson Vascular Center, Thomas Jefferson University Hospitals, Philadelphia, PA 19107, USA
    J Thromb Thrombolysis 32:89-95. 2011
  3. doi request reprint New oral antithrombotic agents for the prevention of deep venous thrombosis and pulmonary embolism in orthopedic surgery
    Geno J Merli
    Jefferson Vascular Center, Thomas Jefferson University Hospital, and Jefferson Medical College, Philadelphia, Pennsylvania 19107, USA
    Orthopedics 33:27-32. 2010
  4. doi request reprint Warfarin: what are the clinical implications of an out-of-range-therapeutic international normalized ratio?
    Geno J Merli
    Jefferson Center for Vascular Diseases, Jefferson Medical College, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA
    J Thromb Thrombolysis 27:293-9. 2009
  5. doi request reprint Pathophysiology of venous thrombosis and the diagnosis of deep vein thrombosis-pulmonary embolism in the elderly
    Geno J Merli
    Jefferson Center for Vascular Diseases, Jefferson Medical College, Thomas Jefferson University Hospital, 833 Chestnut Street, Suite 702, Philadelphia, PA 19107, USA
    Cardiol Clin 26:203-19, vi. 2008
  6. doi request reprint Hospital-based costs associated with venous thromboembolism treatment regimens
    G Merli
    Jefferson Center for Vascular Diseases, Thomas Jefferson University, Philadelphia, PA, USA
    J Thromb Haemost 6:1077-86. 2008
  7. ncbi request reprint Improving venous thromboembolism performance: a comprehensive guide for physicians and hospitalists
    Geno Merli
    Jefferson Center for Vascular Diseases, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Hosp Pract (1995) 38:7-16. 2010
  8. ncbi request reprint Deep-vein thrombosis in malignancy: how long should patients be treated, and with what?
    Geno J Merli
    Hospital Administration, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA
    Catheter Cardiovasc Interv 74:S27-34. 2009
  9. ncbi request reprint Use of emerging oral anticoagulants in clinical practice: translating results from clinical trials to orthopedic and general surgical patient populations
    Geno Merli
    Jefferson Center for Vascular Disease, Thomas Jefferson University Hospitals, Jefferson Medical College, Philadelphia, PA 19107, USA
    Ann Surg 250:219-28. 2009
  10. ncbi request reprint Prevention of thrombosis with warfarin, aspirin, and mechanical methods
    Geno J Merli
    Division of Internal Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Clin Cornerstone 7:49-56. 2005

Detail Information

Publications28

  1. ncbi request reprint The new oral anticoagulants: a challenge for hospital formularies
    Geno J Merli
    Thomas Jefferson University Hospitals, Philadelphia, PA
    Hosp Pract (1995) 40:126-8. 2012
    ..In order to better understand the issues that pharmacy and therapeutics committees will encounter, a review of the 2 FDA-approved oral anticoagulants will be evaluated...
  2. doi request reprint Real-world practices to prevent venous thromboembolism with pharmacological prophylaxis in US orthopedic surgery patients: an analysis of an integrated healthcare database
    G J Merli
    Jefferson Vascular Center, Thomas Jefferson University Hospitals, Philadelphia, PA 19107, USA
    J Thromb Thrombolysis 32:89-95. 2011
    ..Further efforts are required to ensure the recommended duration of thromboprophylaxis is prescribed to all patients and continued outpatient VTE prophylaxis is provided...
  3. doi request reprint New oral antithrombotic agents for the prevention of deep venous thrombosis and pulmonary embolism in orthopedic surgery
    Geno J Merli
    Jefferson Vascular Center, Thomas Jefferson University Hospital, and Jefferson Medical College, Philadelphia, Pennsylvania 19107, USA
    Orthopedics 33:27-32. 2010
    ..This paper will review the current data on the new oral anticoagulants in joint replacement surgery...
  4. doi request reprint Warfarin: what are the clinical implications of an out-of-range-therapeutic international normalized ratio?
    Geno J Merli
    Jefferson Center for Vascular Diseases, Jefferson Medical College, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA
    J Thromb Thrombolysis 27:293-9. 2009
    ..Here, we will assess the extent to which INRs are an issue in the management of warfarin therapy, and the effect INRs may have on clinical outcomes...
  5. doi request reprint Pathophysiology of venous thrombosis and the diagnosis of deep vein thrombosis-pulmonary embolism in the elderly
    Geno J Merli
    Jefferson Center for Vascular Diseases, Jefferson Medical College, Thomas Jefferson University Hospital, 833 Chestnut Street, Suite 702, Philadelphia, PA 19107, USA
    Cardiol Clin 26:203-19, vi. 2008
    ..This foundation will provide the basis for the best care of this disease entity...
  6. doi request reprint Hospital-based costs associated with venous thromboembolism treatment regimens
    G Merli
    Jefferson Center for Vascular Diseases, Thomas Jefferson University, Philadelphia, PA, USA
    J Thromb Haemost 6:1077-86. 2008
    ..With upcoming US national performance measures requiring successful implementation of evidence-based therapy, cost considerations for anticoagulant choice are of increasing importance to hospitals...
  7. ncbi request reprint Improving venous thromboembolism performance: a comprehensive guide for physicians and hospitalists
    Geno Merli
    Jefferson Center for Vascular Diseases, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Hosp Pract (1995) 38:7-16. 2010
    ....
  8. ncbi request reprint Deep-vein thrombosis in malignancy: how long should patients be treated, and with what?
    Geno J Merli
    Hospital Administration, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA
    Catheter Cardiovasc Interv 74:S27-34. 2009
    ..In cancer patients with confirmed VTE, questions remain over the most effective long-term treatment regimen. Further trials are required to help physicians to make evidence-based choices for the management of VTE in these patients...
  9. ncbi request reprint Use of emerging oral anticoagulants in clinical practice: translating results from clinical trials to orthopedic and general surgical patient populations
    Geno Merli
    Jefferson Center for Vascular Disease, Thomas Jefferson University Hospitals, Jefferson Medical College, Philadelphia, PA 19107, USA
    Ann Surg 250:219-28. 2009
    ..A review of clinical data from oral anticoagulant studies in orthopedic/general surgery and extrapolation to actual clinical practice...
  10. ncbi request reprint Prevention of thrombosis with warfarin, aspirin, and mechanical methods
    Geno J Merli
    Division of Internal Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Clin Cornerstone 7:49-56. 2005
    ..Increased awareness about the full range of options for VTE prophylaxis can help health care providers select the appropriate course of action to help reduce the incidence of VTE among patients with acute medical illnesses...
  11. ncbi request reprint Venous thromboembolism prophylaxis guidelines: use by primary care physicians
    Geno J Merli
    Division of Internal Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Clin Cornerstone 7:32-8. 2005
    ..The problem of VTE will grow as the US population ages, as surgery is performed on increasingly sick patients, and as the length of hospital stays continues to decrease...
  12. ncbi request reprint Hospital-based costs associated with venous thromboembolism prophylaxis regimens
    Geno Merli
    Jefferson Vascular Diseases Center, Jefferson Medical College, Thomas Jefferson University Hospital, Suite 6250, Philadelphia, PA 19107, USA
    J Thromb Thrombolysis 29:449-58. 2010
    ..0001). In conclusion, enoxaparin prophylaxis is a cost-saving therapy, when compared with UFH, for the prevention of VTE in patients with a diverse range of medical conditions conferring VTE risk...
  13. ncbi request reprint Quality improvement program: advancement of hospital venous thromboembolism--free zones
    Geno Merli
    Jefferson Medical College, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA
    Am J Manag Care 17:S9-14. 2011
    ..The development of new oral anticoagulants will play an important role in increasing the effectiveness, safety, and convenience of thromboprophylactic therapy, which may improve adherence to guidelines for thromboprophylaxis...
  14. ncbi request reprint The decision to anticoagulate: assessing whether benefits outweigh the risks for patients with atrial fibrillation
    Geno Merli
    Division of Internal Medicine, Department of Medicine, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA
    Clin Cardiol 27:313-20. 2004
    ..Future developments, such as the introduction of oral direct thrombin inhibitors with more predictable pharmacokinetics than warfarin, may further improve the benefit-to-risk ratio of anticoagulation therapy for patients with AF...
  15. ncbi request reprint Pulmonary embolism in medical patients: improved diagnosis and the role of low-molecular-weight heparin in prevention and treatment
    Geno J Merli
    Division of Internal Medicine, Jefferson Medical College, Thomas Jefferson University Hospital, Philadelphia, PA 19106, USA
    J Thromb Thrombolysis 18:117-25. 2004
    ..If a PE is confirmed, then appropriate treatment based on the clinical status of the patient with either LMWH or body-weight dose-adjusted UFH is indicated...
  16. ncbi request reprint Diagnostic assessment of deep vein thrombosis and pulmonary embolism
    Geno Merli
    Jefferson Antithrombotic Therapy Service, Division of Internal Medicine, Thomas Jefferson University Hospital, Jefferson Medical College, Philadelphia, Pennsylvania 19107, USA
    Am J Med 118:3S-12S. 2005
    ..This review offers a clinical perspective on the accurate, routine diagnosis of VTE, including an overview of common clinical signs and symptoms, as well as the advantages and drawbacks of available diagnostic strategies...
  17. ncbi request reprint Anticoagulants in the treatment of deep vein thrombosis
    Geno Merli
    Jefferson Antithrombotic Therapy Service, Division of Internal Medicine, Thomas Jefferson University Hospital, Jefferson Medical College, Philadelphia, Pennsylvania 19107, USA
    Am J Med 118:13S-20S. 2005
    ..The introduction of LMWHs has resulted in significant clinical progress for the treatment of DVT...
  18. ncbi request reprint Pathophysiology of venous thrombosis, thrombophilia, and the diagnosis of deep vein thrombosis-pulmonary embolism in the elderly
    Geno J Merli
    Division of Internal Medicine, Jefferson Antithrombotic Therapy Service, Thomas Jefferson University Hospital, Jefferson Medical College, Philadelphia, PA 19107, USA
    Clin Geriatr Med 22:75-92, viii-ix. 2006
    ..Finally, evaluating symptomatic patients for VTE should be structured to use the appropriate testing to confirm the diagnosis...
  19. ncbi request reprint The physician-hospital team: a successful approach to improving care in a large academic medical center
    Arthur M Feldman
    Jefferson Medical College, Department of Medicine, 1025 Walnut Street, Suite 822, Philadelphia, PA 19107, USA
    Acad Med 81:35-41. 2006
    ..Development of faculty leadership skills and enhanced physician accountability helped in overcoming the challenges of change...
  20. ncbi request reprint Venous thromboembolism in the elderly: risk assessment, prevention, and acute treatment
    Geno Merli
    Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Clin Adv Hematol Oncol 3:339-40. 2005
  21. ncbi request reprint Assessment of venous thromboembolism risk and the benefits of thromboprophylaxis in medical patients
    Alexander T Cohen
    Vascular Medicine, Department of Surgery, Guy s, King s and St Thomas School of Medicine, London, UK
    Thromb Haemost 94:750-9. 2005
    ..These medical conditions and risk factors are included in a risk-assessment model which is hoped will provide a simple means of assisting clinicians in deciding whether thromboprophylaxis should be used in an individual patient...
  22. doi request reprint Relationship of inferior vena cava filter usage in post-surgical patients by various surgical and medical subspecialists
    David B Marmor
    Division of Cardiology, Loyola University Medical Center, Maywood, Illinois, USA
    Am J Cardiol 102:226-30. 2008
    ..The heterogeneity of treatment strategies coupled with the lack of data for this patient population highlights the need for future prospective studies to guide evidence-based treatment...
  23. ncbi request reprint Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: findings from the International Medical Prevention Registry on Venous Thromboembolism
    Victor F Tapson
    Division of Pulmonary and Critical Care, Box 31175, Room 351 Bell Building, Duke University Medical Center, Durham, NC 27710, USA
    Chest 132:936-45. 2007
    ..Our aim was to characterize the clinical practices for VTE prophylaxis in acutely ill hospitalized medical patients enrolled in the International Medical Prevention Registry on Venous Thromboembolism (IMPROVE)...
  24. ncbi request reprint Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation Forum
    David A Garcia
    University of New Mexico School of Medicine, Albuquerque, NM, USA
    Ann Pharmacother 42:979-88. 2008
    ....
  25. doi request reprint Vitamin K and thrombosis
    Geno J Merli
    Professor of Medicine, Director Jefferson Center for Vascular Diseases, Jefferson Medical College, Thomas Jefferson University Hospital, Philadelphia, PA 19107, USA
    Vitam Horm 78:265-79. 2008
    ..These new areas of research highlight the significance of vitamin K but raise new clinical questions for patients who must be maintained on long-term warfarin therapy...
  26. ncbi request reprint Establishing an inpatient anticoagulation service: a step by step review
    John Viercinski
    Department of Pharmacy, Wilkes Barre General Hospital, Wilkes Barre, PA 18764, USA
    J Thromb Thrombolysis 25:67-71. 2008
    ..The size and scope of the service should be based upon the needs, experiences and resources of a specific institution...
  27. ncbi request reprint Atrial fibrillation and strokes: new drugs and a new attitude
    Charles S Abrams
    Division of Hematology Oncology, University of Pennsylvania, Philadelphia, USA
    Am J Manag Care 10:S48-9. 2004
  28. ncbi request reprint Current pharmacotherapeutic options for treating deep vein thrombosis
    Geno J Merli
    Department of Medicine, Jefferson Medical College, Thomas Jefferson University Hospital, PA, USA
    Expert Opin Pharmacother 4:55-65. 2003
    ..This paper will review the management of DVT from the acute phase to long-term management...